Open aortic aneurysm repair in the endovascular era

L. Davidovic, David Matejević, Ognjen Kostić
{"title":"Open aortic aneurysm repair in the endovascular era","authors":"L. Davidovic, David Matejević, Ognjen Kostić","doi":"10.5937/medi55-37621","DOIUrl":null,"url":null,"abstract":"Open repair (OR) of aortic aneurysms is still relatively mutilating and risky in older and high-risk patients. Since the introduction of EVAR, a significantly lower perioperative mortality has been noted. Apart from advantages, endovascular treatment has some disadvantages as well, due to which OR still has a very important role in the endovascular era. In a vast majority of the patients younger than 65, with good overall condition, long life expectancy and favorable anatomy, as well as in patients with hostile aneurysm neck anatomy, heritable connective tissue disorders, complete thrombosis of abdominal aortic aneurysm (AAA) and potent accessory renal arteries, OR is the first treatment option in comparison with the endovascular treatment. EVAR is recommended as the first treatment option in patients with inflammatory aneurysms and OR should be considered only in better shaped patients with inflammatory AAA and significant hydronephrosis. Late open surgical conversion (LOSC) is a noted event after endovascular treatment and is associated with a significantly higher perioperative mortality and other serious perioperative complications compared to primary OR. Multicenter randomized controlled trials (RCT) did not find a significant difference regarding 30-day mortality between open and endovascular repair of ruptured AAA. However, not all ruptured AAA are suitable for endovascular repair. In a hemodynamically unstable patients, when there is no time for MDCT angiography, EVAR is not possible, and OR is the only option. The incidence of abdominal compartment syndrome after OR is significantly lower in comparison with EVAR thanks to surgical evacuation and drainage of retroperitoneal hematoma. The improvement of the results of aortic aneurysm treatment largely depends on the volume of yearly aortic operations. Having in mind all the mentioned advantages and disadvantages of OR and endovascular repair, we can conclude that in high volume centers, younger generations of vascular surgeons should be educated in standard and complex open aortic surgery.","PeriodicalId":167411,"journal":{"name":"Medicinska istrazivanja","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinska istrazivanja","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/medi55-37621","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Open repair (OR) of aortic aneurysms is still relatively mutilating and risky in older and high-risk patients. Since the introduction of EVAR, a significantly lower perioperative mortality has been noted. Apart from advantages, endovascular treatment has some disadvantages as well, due to which OR still has a very important role in the endovascular era. In a vast majority of the patients younger than 65, with good overall condition, long life expectancy and favorable anatomy, as well as in patients with hostile aneurysm neck anatomy, heritable connective tissue disorders, complete thrombosis of abdominal aortic aneurysm (AAA) and potent accessory renal arteries, OR is the first treatment option in comparison with the endovascular treatment. EVAR is recommended as the first treatment option in patients with inflammatory aneurysms and OR should be considered only in better shaped patients with inflammatory AAA and significant hydronephrosis. Late open surgical conversion (LOSC) is a noted event after endovascular treatment and is associated with a significantly higher perioperative mortality and other serious perioperative complications compared to primary OR. Multicenter randomized controlled trials (RCT) did not find a significant difference regarding 30-day mortality between open and endovascular repair of ruptured AAA. However, not all ruptured AAA are suitable for endovascular repair. In a hemodynamically unstable patients, when there is no time for MDCT angiography, EVAR is not possible, and OR is the only option. The incidence of abdominal compartment syndrome after OR is significantly lower in comparison with EVAR thanks to surgical evacuation and drainage of retroperitoneal hematoma. The improvement of the results of aortic aneurysm treatment largely depends on the volume of yearly aortic operations. Having in mind all the mentioned advantages and disadvantages of OR and endovascular repair, we can conclude that in high volume centers, younger generations of vascular surgeons should be educated in standard and complex open aortic surgery.
血管内时代的开放性主动脉瘤修复
对于高龄和高危患者,开放式修复(OR)仍然是相对致残和危险的。自引入EVAR以来,围手术期死亡率显著降低。血管内治疗有其优点,也有其缺点,因此在血管内治疗时代,OR仍然具有非常重要的作用。对于绝大多数年龄小于65岁、整体状况良好、预期寿命长、解剖结构有利的患者,以及动脉瘤颈部解剖不良、遗传性结缔组织疾病、腹主动脉瘤完全血栓形成(AAA)和肾副动脉强效的患者,相比于血管内治疗,OR是首选治疗方案。EVAR被推荐作为炎性动脉瘤患者的首选治疗方案,只有在形状较好的炎症性AAA和明显肾积水患者中才应考虑OR。晚期开放手术转换(LOSC)是血管内治疗后的一个值得注意的事件,与原发性OR相比,其围手术期死亡率和其他严重的围手术期并发症明显更高。多中心随机对照试验(RCT)未发现开放和血管内修复AAA破裂的30天死亡率有显著差异。然而,并非所有AAA破裂都适合血管内修复。在血流动力学不稳定的患者中,当没有时间进行MDCT血管造影时,EVAR是不可能的,而OR是唯一的选择。由于手术引流腹膜后血肿,OR术后腹腔隔室综合征的发生率明显低于EVAR。动脉瘤治疗效果的改善很大程度上取决于每年主动脉手术的数量。考虑到所有提到的OR和血管内修复的优点和缺点,我们可以得出结论,在大容量中心,年轻一代的血管外科医生应该接受标准和复杂的主动脉切开手术的教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信